Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Net Income 2023–2025
Monte Rosa Therapeutics, Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Monte Rosa Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -44.5 M, a 194.92% decrease year-over-year.
- Monte Rosa Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -37.0 M, a 69.43% decrease year-over-year.
- Monte Rosa Therapeutics, Inc. annual net income for 2025 was -38.6 M, a 46.87% decrease from 2024.
- Monte Rosa Therapeutics, Inc. annual net income for 2024 was -72.7 M, a 46.29% decrease from 2023.
- Monte Rosa Therapeutics, Inc. annual net income for 2023 was -135.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Monte Rosa Therapeutics, Inc. Net Income — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Monte Rosa Therapeutics, Inc.'s net income?
Monte Rosa Therapeutics, Inc. (GLUE) reported net income of -$39M for fiscal 2025.
Where can I see GLUE's net income history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.